Related keylists
Sichuan Kelun Pharmaceutical Catalyst Calendar
Proactively evaluate Sichuan Kelun Pharmaceutical Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Sichuan Kelun Pharmaceutical Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
31 Aug 2020 | Phase II Trial Completion | Sichuan Kelun Pharmaceutical Co Ltd | 002422 | KLA-167 | Oncology | Carcinomas; Nasopharyngeal Cancer | Clinical Trial Registry |
01 Aug 2020 | Phase IV Trial Initiation | Chizhou People's Hospital; Sichuan Kelun Pharmaceutical Co Ltd | 002422 | zoledronic acid | Musculoskeletal Disorders | Bone Fracture; Osteoporosis | Clinical Trial Registry |
01 Feb 2020 | Phase I/II Trial Initiation | KLUS Pharma Inc; Sichuan Kelun Pharmaceutical Co Ltd | 002422 | SKB-264 | Oncology | Adenocarcinoma Of The Gastroesophageal Junction; Breast Cancer; Endometrial Cancer; Epithelial Ovarian Cancer; Gastric Cancer; Head And Neck Cancer Squamous Cell Carcinoma; Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer); Metastatic Transitional (Urothelial) Tract Cancer; Non-Small Cell Lung Cancer; Small-Cell Lung Cancer; Solid Tumor; Transitional Cell Carcinoma (Urothelial Cell Carcinoma); Triple-Negative Breast Cancer (TNBC) | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer